About Serous carcinoma of the corpus uteri
Serous carcinoma of the corpus uteri is a rare disease catalogued by Orphanet (ORPHA:213726). It is associated with the ERBB2 gene. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Serous carcinoma of the corpus uteri trials.
Search ClinicalTrials.gov for "Serous carcinoma of the corpus uteri" or filter by Orphanet code ORPHA:213726 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Serous carcinoma of the corpus uteri trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Serous carcinoma of the corpus uteri. Updated daily.